SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-----------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
-----------------------
Date of Report
(Date of earliest
event reported): September 20, 2000
Banta Corporation
----------------------------------------------------
(Exact name of registrant as specified in its charter)
Wisconsin 0-6187 39-0148550
- --------------- -------------------- ----------
(State or other (Commission File (IRS Employer
jurisdiction of Number) Identification No.)
incorporation)
225 Main Street, Menasha, Wisconsin 54952
----------------------------------------------------------
(Address of principal executive offices, including zip code)
(920) 751-7777
-----------------------------
(Registrant's telephone number)
Item 5. Other Events.
- ------ ------------
On September 20, 2000, Banta Corporation (the "Company") held a
meeting for analysts to discuss the Company's current operations and plans. A
copy of the scripts (the "Scripts") for such meeting is filed as Exhibit 99.1
and is incorporated by reference herein. An audio replay of such meeting and the
related question and answer session will be available for thirty days on the
Company's web site at www.banta.com.
The information, including, without limitation, all forward-looking
statements, contained in the Scripts or provided in the meeting and related
question and answer session speaks only as of September 20, 2000. The Company
assumes no obligation, and disclaims any obligation, to update information
contained in the Scripts or provided in the meeting and related question and
answer session. Investors should be aware that the Company may not update such
information.
The Scripts and representations of the Company made during the meeting
and the related question and answer session contain "forward-looking statements"
that are believed to be within the meaning of the Private Securities Litigation
Reform Act of 1995. All statements other than statements of historical fact
included in the Scripts or made during the related question and answer session,
including, without limitation, statements regarding the Company's future
financial position, business strategy, targets, projected sales, costs,
earnings, capital expenditures and debt levels, and plans and objectives of
management for future operations, are forward-looking statements. In addition,
forward-looking statements generally can be identified by the use of
forward-looking terminology such as "may," "will," "expect," "intend,"
"estimates," "anticipate," "believe," "should" or "plans," or the negative
thereof or variations thereon or similar terminology. Important factors that
could cause actual results to differ materially from the Company's expectations
include, without limitation, the following: changes in customers' order patterns
or demand for the Company's products, unanticipated changes in the level of
capital expenditures, changes in interest rates, changes in raw material costs
and availability (especially paper), success with operational start-ups, and
general changes in economic conditions. These factors should be considered in
evaluating the forward-looking statements, and undue reliance should not be
placed on such statements.
Additional information concerning factors that could cause actual
results to differ materially from those in the forward-looking statements is
contained from time to time in the Company's filings with the Securities and
Exchange Commission, including, but not limited to, the Company's Annual Report
on Form 10-K for the fiscal year ended January 1, 2000. All subsequent written
and oral forward-looking statements attributable to the Company, or persons
acting on its behalf, are expressly qualified in their entirety by the
cautionary statements contained in this Current Report on Form 8-K and the
Company's other filings with the Securities and Exchange Commission.
Item 7. Financial Statements and Exhibits.
- ------ ---------------------------------
(a) Not applicable.
(b) Not applicable.
(c) Exhibits. The following exhibit is being filed herewith:
(99.1) Scripts for Analyst Meeting Held September 20,
2000.
-2-
SIGNATURES
----------
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
BANTA CORPORATION
Date: September 20, 2000 By: /s/ Ronald D. Kneezel
----------------------------------
Ronald D. Kneezel
Vice President, General Counsel
and Secretary
-3-
BANTA CORPORATION
Exhibit Index to Current Report on Form 8-K
Dated September 20, 2000
Exhibit
Number
- -------
(99.1) Scripts for Analyst Meeting Held September 20, 2000.
-4-